Charles Duncan Maintained (ACAD) at Buy with Increased Target to $27 on, Oct 16th, 2018
Charles has made no other calls on ACAD in the last 4 months.
There are 3 other peers that have a rating on ACAD. Out of the 3 peers that are also analyzing ACAD, 1 agrees with Charles's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Matteis Paul of "Stifel" Maintained at Hold with Decreased Target to $14 on, Thursday, August 9th, 2018
These are the ratings of the 2 analyists that currently disagree with Charles
- Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy with Increased Target to $25 on, Wednesday, October 10th, 2018
- Jason Butler of "JMP Securities" Maintained at Buy with Decreased Target to $27 on, Thursday, August 9th, 2018
on: Wed, Oct 10th 2018
by: WOPRAI
Tazeen Ahmad Maintained (ACAD) at Strong Buy with Increased Target to $25 on, Oct 10th, 2018
on: Mon, Oct 01st 2018
by: WOPRAI
Olivia Brayer Initiated (ALNY) at Buy and Held Target at $135 on, Oct 1st, 2018
on: Thu, Aug 23rd 2018
by: WOPRAI
Charles Duncan Initiated (ACAD) at Buy and Held Target at $25 on, Aug 23rd, 2018
on: Thu, Jan 25th 2018
by: WOPRAI
Paul Matteis Maintained (ALNY) at Hold with Increased Target to $135 on, Jan 25th, 2018
on: Mon, Dec 11th 2017
by: WOPRAI
Georgios Mihalos Initiated (SQ) at Hold and Held Target at $36 on, Dec 11th, 2017
on: Mon, Nov 27th 2017
by: WOPRAI
Mark Palmer Downgraded (SQ) to Strong Sell on, Nov 27th, 2017
on: Tue, Nov 21st 2017
by: WOPRAI
Timothy Willi Initiated (SQ) at Hold and Held Target at $42 on, Nov 21st, 2017
on: Mon, Nov 20th 2017
by: WOPRAI
Paul Condra Maintained (SQ) at Hold with Increased Target to $37 on, Nov 20th, 2017
on: Fri, Nov 17th 2017
by: WOPRAI
on: Thu, Nov 16th 2017
by: WOPRAI
Dan Dolev Maintained (SQ) at Strong Buy with Increased Target to $48 on, Nov 16th, 2017
on: Mon, Nov 13th 2017
by: WOPRAI
Ramsey El-Assal Maintained (SQ) at Strong Buy with Increased Target to $44 on, Nov 13th, 2017
on: Fri, Nov 10th 2017
by: WOPRAI
Jed Kelly Maintained (SQ) at Buy with Increased Target to $41 on, Nov 10th, 2017